Brighton Jones LLC Buys New Holdings in Centene Corporation (NYSE:CNC)

Brighton Jones LLC purchased a new stake in shares of Centene Corporation (NYSE:CNC - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 5,345 shares of the company's stock, valued at approximately $324,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Capital Advisors Ltd. LLC lifted its holdings in Centene by 75.3% during the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company's stock valued at $25,000 after purchasing an additional 177 shares during the last quarter. Pinney & Scofield Inc. bought a new position in Centene during the 4th quarter valued at about $25,000. Hurley Capital LLC acquired a new stake in Centene in the 4th quarter valued at about $26,000. Ameriflex Group Inc. acquired a new stake in Centene in the 4th quarter valued at about $26,000. Finally, Rialto Wealth Management LLC acquired a new stake in Centene in the 4th quarter valued at about $30,000. 93.63% of the stock is owned by institutional investors.

Centene Stock Up 0.3%

Shares of CNC stock traded up $0.17 during trading on Thursday, reaching $55.08. The company's stock had a trading volume of 4,751,598 shares, compared to its average volume of 4,912,068. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.65. The business has a fifty day moving average price of $58.83 and a 200-day moving average price of $59.81. Centene Corporation has a one year low of $53.99 and a one year high of $80.59. The company has a market cap of $27.41 billion, a price-to-earnings ratio of 8.21, a price-to-earnings-growth ratio of 0.66 and a beta of 0.45.

Centene (NYSE:CNC - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $2.90 EPS for the quarter, beating the consensus estimate of $2.52 by $0.38. Centene had a net margin of 2.04% and a return on equity of 14.56%. The firm had revenue of $46.62 billion for the quarter, compared to the consensus estimate of $43.16 billion. During the same period in the previous year, the company earned $2.26 earnings per share. The company's quarterly revenue was up 15.4% on a year-over-year basis. Analysts anticipate that Centene Corporation will post 6.86 earnings per share for the current year.

Analyst Ratings Changes

CNC has been the subject of several research reports. Barclays restated an "equal weight" rating and issued a $65.00 price objective (down previously from $84.00) on shares of Centene in a research report on Monday, June 2nd. Guggenheim restated a "neutral" rating on shares of Centene in a research report on Tuesday, April 29th. Wall Street Zen cut shares of Centene from a "strong-buy" rating to a "buy" rating in a research report on Monday, April 28th. Jefferies Financial Group lowered their price target on shares of Centene from $64.00 to $61.00 and set a "hold" rating for the company in a research report on Tuesday, April 29th. Finally, Robert W. Baird lowered their price target on shares of Centene from $71.00 to $69.00 and set a "neutral" rating for the company in a research report on Tuesday, April 15th. Seven analysts have rated the stock with a hold rating and ten have issued a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $77.71.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.